GRACE principles: recognizing high-quality observational studies of comparative effectiveness.
暂无分享,去创建一个
Richard E Gliklich | Nancy A Dreyer | Sebastian Schneeweiss | Marc L Berger | B. McNeil | N. Dreyer | S. Schneeweiss | R. Gliklich | M. Berger | D. Ollendorf | Daniel A Ollendorf | Barbara J McNeil | Alec M Walker
[1] Jan P Vandenbroucke,et al. STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK... and CONSORT: for whom does the guideline toll? , 2009, Journal of clinical epidemiology.
[2] A. Hartz,et al. A comparison of observational studies and randomized, controlled trials. , 2000, The New England journal of medicine.
[3] N. Dreyer,et al. Registries for Evaluating Patient Outcomes: A User’s Guide , 2010 .
[4] Timothy L. Lash,et al. Applying Quantitative Bias Analysis to Epidemiologic Data , 2009, Statistics for Biology and Health.
[5] Elliott S Fisher,et al. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. , 2007, JAMA.
[6] G. Gravlee. Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death , 2009 .
[7] M Alan Brookhart,et al. Instrumental Variable Analysis of Secondary Pharmacoepidemiologic Data , 2006, Epidemiology.
[8] K. Rothman,et al. Mortality in current and former users of clozapine , 1996, Schizophrenia Research.
[9] Clarence Balden Randall,et al. Report to the President and the Congress , 1954 .
[10] G. Guyatt,et al. Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.
[11] W. Ray,et al. Evaluating medication effects outside of clinical trials: new-user designs. , 2003, American journal of epidemiology.
[12] F. Song,et al. Evaluating non-randomised intervention studies. , 2003, Health technology assessment.
[13] Michael L. Johnson,et al. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[14] S. Potkin,et al. The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients. , 2004, Schizophrenia bulletin.
[15] Dawei Xie,et al. Replicated studies of two randomized trials of angiotensin‐ converting enzyme inhibitors: further empiric validation of the ‘prior event rate ratio’ to adjust for unmeasured confounding by indication , 2008, Pharmacoepidemiology and drug safety.
[16] Til Stürmer,et al. Indications for propensity scores and review of their use in pharmacoepidemiology. , 2006, Basic & clinical pharmacology & toxicology.
[17] David Atkins,et al. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[18] W. Baine,et al. The Agency for Healthcare Research and Quality , 2006, Italian Journal of Public Health.
[19] I. Persson,et al. European Medicines Agency review of post‐authorisation studies with implications for the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance , 2011, Pharmacoepidemiology and drug safety.
[20] Canary Wharf,et al. The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) , 2012 .
[21] J. Avorn,et al. Increasing Levels of Restriction in Pharmacoepidemiologic Database Studies of Elderly and Comparison With Randomized Trial Results , 2007, Medical care.
[22] M Alan Brookhart,et al. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. , 2005, American journal of epidemiology.
[23] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[24] Matthias Egger,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.
[25] J. Concato,et al. Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.
[26] H. Tilson,et al. The Antiretrovirals in Pregnancy Registry: A Fifteenth Anniversary Celebration , 2007, Obstetrical & gynecological survey.
[27] M. Epstein,et al. Guidelines for good pharmacoepidemiology practices (GPP) , 2008 .
[28] H. Krumholz,et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. , 2009, JAMA.
[29] David A. Brodie,et al. CLINICAL TRIALS VERSUS THE REAL WORLD: THE EXAMPLE OF CARDIAC REHABILITATION , 2008 .